Pfizer Inc. today announced that its wholly-owned
subsidiary, Parker Tennessee Corp., has extended the expiration date of its
tender offer for all outstanding shares of common stock of King Pharmaceuticals,
Inc. for $14.25 per share, net to the seller in cash, without interest thereon
and subject to any required withholding taxes. The tender offer is now
scheduled to expire at 12:00 midnight, New York City time on Friday, December
17, 2010 (which is the end of the day on December 17, 2010), unless further
extended. The tender offer was previously scheduled to expire at 12:00
midnight, New York City
time, on Friday, November 19, 2010. All other terms and conditions of the
tender offer remain unchanged.